StockMacro
Menu

Prelude Therapeutics

PRLD on XNAS, Prelude Therapeutics Incorporated

Measures activity, not value. Not investment advice.

Latest month (Mar 2025)

1

0.7× the 3-year median

Last 12 months

3

+200% vs the 12 months before

Sharp changes

0

H-1B/E-3 applications change

Median offered wage (Mar 2025) The median yearly wage offered in the visa applications certified that month.

$73K

H-1B/E-3 applications that month

Not enough history to draw

Worksite states (Mar 2025) How many US states the jobs in the company's visa applications are located in.

1

states named in that month's visa applications

Window

What usually follows Visa hiring growth was not followed by a clear share-price difference over the next 6 months. No relationship found How we measured it

H-1B/E-3 applications certified: 1 in March 2025, 0.7× the 3-year median

DOL visa applications by month; published quarterly. Dashed: 3-year median.

See the numbers
Month of Mar 2025: 1
Month of Aug 2024: 2
Month of May 2023: 1
Month of May 2022: 1
Month of Apr 2022: 2
Month of Apr 2021: 2
Month of Feb 2020: 1

What the numbers say

  • H-1B/E-3 applications certified: 1 in March 2025, 0.7× the 3-year median; the most since Aug 2024.

Every measure from this source

5 years, by the period each figure describes

Applications certified. 3 in the last 12 months, +200% on the year before.
Positions certified. 3 in the last 12 months, +200% on the year before.
New-hire positions. 0 in the last 12 months, -100% on the year before.
Applications denied or withdrawn. 1 in the latest period.
Offered wage. $73K in the latest period, -14% on a year earlier.
Worksite states. 1 in the latest period, 0% on a year earlier.

Sharp changes

0 in all loaded history, strongest first

No sharp change of this kind in all loaded history.

The records

One row per company, data through 28 Sep 2026

Showing 1 to 1 of 1.
CompanySectorLast 12 monthsvs year before
Prelude TherapeuticsHealth Care0-100%